Rare diseases
Investigational molecules
Locations
Study of Ibrutinib for Patients with Chronic Lymphocytic Leukemia and TP53 Mutations
ItalyStudy on Ibrutinib and Venetoclax for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
ItalyStudy on the Safety and Effectiveness of Azacitidine and Pembrolizumab for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Platinum Treatment
ItalyStudy of RMC-035 to prevent kidney injury in patients undergoing open-chest heart surgery
CzechiaStudy on the Safety and Effects of LY3884963 for Patients with Fronto-Temporal Dementia with Progranulin Mutations
BelgiumStudy on Upadacitinib for Children with Moderate to Severe Crohn's Disease
BelgiumStudy of Osimertinib and Savolitinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Osimertinib Treatment
ItalyStudy of Lebrikizumab and Mometasone Furoate for Adults with Perennial Allergic Rhinitis
BelgiumStudy on [18F]mFBG PET-CT Imaging for Patients with Pheochromocytoma
The NetherlandsStudy on Efinopegdutide for Adults with Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatohepatitis
FranceStudy on Niraparib for Patients with HER2-Negative BRCA-Mutated or Triple-Negative Breast Cancer with Molecular Disease Detected by ctDNA
ItalyStudy Comparing Rituximab and Ocrelizumab for Patients with Active Multiple Sclerosis
DenmarkTell us about your condition – we search every trial in Europe and connect you with the right site.
